Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Akathisia Induced by Abrupt Withdrawal of Risperidone: A Case Report
2
x
$
30.00
The Use of Complementary Alternative Medicine in Children and Adolescents with Autism Spectrum Disorder
1
x
$
30.00
Unmet Medication Coverage Needs among Adults with Attention Deficit/Hyperactivity Disorder (ADHD)
1
x
$
30.00
Vicki L. Ellingrod, PharmD, BCPP: Leptin and Leptin Receptor Gene Polymorphisms and Increases in Body Mass Index (BMI) from Olanzapine Treatment in Persons with Schizophrenia
1
x
$
30.00
Zonisamide for Bipolar Depression by Deborah Dauphinais
1
x
$
30.00
Thomas J. Raedler, MD: Lithium-Induced Nephropathies
1
x
$
30.00
Schizophrenia Rating Scales Critical Review by Takefumi Suzuki
1
x
$
30.00
Re: An Interesting Presentation About Cyclical Menstrual Psychosis with an Updated Review of Literature
1
x
$
30.00
Atomoxetine Induced Hypothermia by Onat Yilmaz
1
x
$
30.00
View Cart
Checkout
Home
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
“Atomoxetine Induced Hypothermia by Onat Yilmaz” has been added to your cart.
View cart
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
$
30.00
C. Lindsay DeVane, PharmD: An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 35 No. 1 Articles
Tags:
c-lindsay-devane
,
dosage-regimen-design
,
heidi-l-liston
,
medworks-media
,
pharmacokinetics
,
psychopharmacology
,
psychopharmacology-bulletin
,
second-dose-effect
Description
Description
C. Lindsay DeVane, PharmD
DRUG INTERACTIONS
An Explanation of the Second-Dose Effect in Pharmacokinetics and Its Meaning for Clinical Psychopharmacology
C. Lindsay DeVane, PharmD, and Heidi L. Liston, PharmD
Related products
Clozapine Factors in Schizophrenia by Takefumi Suzuki
$
30.00
Add to cart
Details
Clozapine Related Suicidal Obsession by Branka Aukst-Margetic
$
30.00
Add to cart
Details
Euprolactinemic Gynecomastia and Galactorrhea with Risperidone-Fluvoxamine Combination by Samir Kumar Praharaj
$
30.00
Add to cart
Details
Vilazodone – Safety and Tolerability Profile PB VOL 44 No. 3
$
30.00
Add to cart
Details
Page load link
Go to Top